Burkhard Blank
2017
In 2017, Burkhard Blank earned a total compensation of $1.5M as Chief Medical Officer at Acorda Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,610 |
|---|---|
| Option Awards | $515,659 |
| Salary | $531,750 |
| Stock Awards | $288,488 |
| Other | $11,062 |
| Total | $1,477,569 |
Blank received $531.8K in salary, accounting for 36% of the total pay in 2017.
Blank also received $130.6K in non-equity incentive plan, $515.7K in option awards, $288.5K in stock awards and $11.1K in other compensation.
Rankings
In 2017, Burkhard Blank's compensation ranked 7,061st out of 14,666 executives tracked by ExecPay. In other words, Blank earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,061 out of 14,666 | 52nd |
Division Manufacturing | 2,620 out of 5,772 | 55th |
Major group Chemicals And Allied Products | 852 out of 2,075 | 59th |
Industry group Drugs | 663 out of 1,731 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 124 out of 313 | 60th |
Source: SEC filing on April 27, 2018.
Blank's colleagues
We found five more compensation records of executives who worked with Burkhard Blank at Acorda Therapeutics in 2017.
2017
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2017
Andrew Hindman
Acorda Therapeutics
Chief Business Officer
2017
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2017
Jane Wasman
Acorda Therapeutics
General Counsel
2017
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
News
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019